Fredun Pharmaceuticals
Fredun Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Fredun Pharmaceuticals
Start SIPFredun Pharmaceuticals Investment Rating
-
Master Rating:
-
Fredun Pharmaceuticals has an operating revenue of Rs. 264.06 Cr. on a trailing 12-month basis. An annual revenue growth of 67% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 62%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 78 | 69 | 48 | 69 |
| Operating Expenses Qtr Cr | 71 | 64 | 45 | 66 |
| Operating Profit Qtr Cr | 7 | 5 | 4 | 3 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 2 | 2 | 2 | 2 |
| Tax Qtr Cr | 1 | 1 | 0 | 1 |
| Net Profit Qtr Cr | 3 | 3 | 1 | 2 |
Fredun Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- 886.01
- 50 Day
- 959.48
- 100 Day
- 1017.62
- 200 Day
- 1010.4
- 20 Day
- 882.69
- 50 Day
- 965.88
- 100 Day
- 1098
- 200 Day
- 1040.73
Fredun Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 889.7 |
| Second Resistance | 928.15 |
| Third Resistance | 958 |
| RSI | 41.64 |
| MFI | 35.91 |
| MACD Single Line | -39.1 |
| MACD | -38.54 |
| Support | |
|---|---|
| First Resistance | 821.4 |
| Second Resistance | 791.55 |
| Third Resistance | 753.1 |
Fredun Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,912 | 140,800 | 73.64 |
| Week | 4,061 | 352,216 | 86.74 |
| 1 Month | 3,346 | 266,992 | 79.8 |
| 6 Month | 2,887 | 223,723 | 77.49 |
Fredun Pharmaceuticals Result Highlights
Fredun Pharmaceuticals Synopsis
BSE-Medical-Diversified
Fredun Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 224.46 Cr. and Equity Capital is Rs. 4.43 Cr. for the Year ended 31/03/2022. Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662.| Market Cap | 388 |
| Sales | 264 |
| Shares in Float | 0.23 |
| No of funds | 1 |
| Yield | 0.08 |
| Book Value | 5.63 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | 62 |
| Alpha | 0.01 |
| Beta | 1.01 |
Fredun Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 50.34% | 51.04% | 51.04% | |
| Financial Institutions/ Banks | 1.66% | 1.68% | 1.68% | |
| Individual Investors | 42.48% | 42.02% | 42.02% | |
| Others | 5.52% | 5.26% | 5.26% |
Fredun Pharmaceuticals Management
| Name | Designation |
|---|---|
| Dr.(Mrs.) Daulat N Medhora | Chairman & Jt. M. D |
| Mr. Fredun Medhora | Managing Director & CFO |
| Mr. Nariman Medhora | Non Executive Director |
| Dr. Chandrakant Shah | Ind. Non-Executive Director |
| Dr. Rohinton Kanga | Ind. Non-Executive Director |
| Dr. Aspi Raimalwala | Ind. Non-Executive Director |
Fredun Pharmaceuticals Forecast
Price Estimates
Fredun Pharmaceuticals FAQs
What is Share Price of Fredun Pharmaceuticals ?
Fredun Pharmaceuticals share price is ₹865 As on 22 March, 2023 | 04:29
What is the Market Cap of Fredun Pharmaceuticals ?
The Market Cap of Fredun Pharmaceuticals is ₹392 Cr As on 22 March, 2023 | 04:29
What is the P/E ratio of Fredun Pharmaceuticals ?
The P/E ratio of Fredun Pharmaceuticals is 39.8 As on 22 March, 2023 | 04:29
What is the PB ratio of Fredun Pharmaceuticals ?
The PB ratio of Fredun Pharmaceuticals is 5.8 As on 22 March, 2023 | 04:29